These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6933470)
21. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study. Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137 [TBL] [Abstract][Full Text] [Related]
22. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010. Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683 [TBL] [Abstract][Full Text] [Related]
23. Monitoring exposure to atomic bomb radiation by somatic mutation. Akiyama M; Kyoizumi S; Kusunoki Y; Hirai Y; Tanabe K; Cologne JB Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):493-6. PubMed ID: 8781371 [TBL] [Abstract][Full Text] [Related]
24. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Biochemical genetics study. Satoh C J Radiat Res; 1991 Mar; 32 Suppl():378-84. PubMed ID: 1762126 [TBL] [Abstract][Full Text] [Related]
25. Implications of the Hiroshima-Nagasaki genetic studies for the estimation of the human "doubling dose" of radiation. Neel JV; Schull WJ; Awa AA; Satoh C; Otake M; Kato H; Yoshimoto Y Genome; 1989; 31(2):853-9. PubMed ID: 2698842 [TBL] [Abstract][Full Text] [Related]
27. Individual variation of somatic gene mutability in relation to cancer susceptibility: prospective study on erythrocyte glycophorin a gene mutations of atomic bomb survivors. Kyoizumi S; Kusunoki Y; Hayashi T; Hakoda M; Cologne JB; Nakachi K Cancer Res; 2005 Jun; 65(12):5462-9. PubMed ID: 15958596 [TBL] [Abstract][Full Text] [Related]
28. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons. Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767 [TBL] [Abstract][Full Text] [Related]
29. Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors. Zhang W; Muirhead CR; Hunter N J Radiol Prot; 2005 Dec; 25(4):393-404. PubMed ID: 16340068 [TBL] [Abstract][Full Text] [Related]
30. Incidence of intracranial meningiomas in Nagasaki atomic-bomb survivors. Sadamori N; Shibata S; Mine M; Miyazaki H; Miyake H; Kurihara M; Tomonaga M; Sekine I; Okumura Y Int J Cancer; 1996 Jul; 67(3):318-22. PubMed ID: 8707402 [TBL] [Abstract][Full Text] [Related]
31. Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: a comparative study of assay methods. Langlois RG; Akiyama M; Kusunoki Y; DuPont BR; Moore DH; Bigbee WL; Grant SG; Jensen RH Radiat Res; 1993 Oct; 136(1):111-7. PubMed ID: 8210326 [TBL] [Abstract][Full Text] [Related]
32. Thyroid diseases among atomic bomb survivors in Nagasaki. Nagataki S; Shibata Y; Inoue S; Yokoyama N; Izumi M; Shimaoka K JAMA; 1994 Aug; 272(5):364-70. PubMed ID: 8028167 [TBL] [Abstract][Full Text] [Related]
33. Lack of effects of atomic bomb radiation on genetic instability of tandem-repetitive elements in human germ cells. Kodaira M; Satoh C; Hiyama K; Toyama K Am J Hum Genet; 1995 Dec; 57(6):1275-83. PubMed ID: 8533756 [TBL] [Abstract][Full Text] [Related]
34. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Langlois RG; Bigbee WL; Kyoizumi S; Nakamura N; Bean MA; Akiyama M; Jensen RH Science; 1987 Apr; 236(4800):445-8. PubMed ID: 3563520 [TBL] [Abstract][Full Text] [Related]
35. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki. Otake M; Schull WJ Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422 [No Abstract] [Full Text] [Related]
36. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971. Ishimaru T; Otake M; Ischimaru M Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375 [No Abstract] [Full Text] [Related]
38. [Review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. The Japan Radiation Research Society Chiba. Japan, September, 1975]. Gus'kova AK; Sadchikova EN Med Radiol (Mosk); 1977 Aug; 22(8):69-77. PubMed ID: 927066 [No Abstract] [Full Text] [Related]
39. Genetic markers in the atomic bomb survivors and their children--Hiroshima and Nagasaki. Hamilton HB Jinrui Idengaku Zasshi; 1982 Jun; 27(2):113-9. PubMed ID: 6960207 [No Abstract] [Full Text] [Related]
40. Radiation risk of individual multifactorial diseases in offspring of the atomic-bomb survivors: a clinical health study. Tatsukawa Y; Cologne JB; Hsu WL; Yamada M; Ohishi W; Hida A; Furukawa K; Takahashi N; Nakamura N; Suyama A; Ozasa K; Akahoshi M; Fujiwara S; Shore R J Radiol Prot; 2013 Jun; 33(2):281-93. PubMed ID: 23482396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]